Fundraising Fox

GENERAL INCEPTION

Venture studio

Palo Alto · Pre-Seed–Seed · 41 people tracked

Also known as GENERAL INCEPTION MANAGEMENT, LLC

Fox Verdict
Sign up to see your fit

Investment thesis

General Inception acts as a business co-founder for scientific and technical entrepreneurs building science-based companies. Its model centers on assembling the right people, customers, and funding partners at the optimal time for company formation and growth. GI supports founders across legal, financial, business strategy, and operational challenges, partnering through company formation, product development, and institutional fundraising. Its portfolio forms an interconnected ecosystem that shares access to new technologies, customers, and markets. The firm focuses on translating deep tech visions into customer-facing businesses, guiding founders from initial idea through seed-stage investment and beyond.

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Seed
HQ
Palo Alto, CA, US
Leads rounds
Follows
Instruments
Equity
Private fund assets
$52.2M
VC funds
1
Tracked investments
42

Team · 41 people

from the firm's website & public directories
Paul Conley· Chairman & CEOin
Carol Tillis· Financein
Elisabeth Gardiner· Strategic Advisorin
Elodie Dormes· Business Developmentin
Francois Valencony· Chief Business Officer
Ingrid Caton· Program Managerin
John Saunders· Business Operations
Kelli Zimmerman· Administrative Staffin
Loïc Vincent· Strategic Advisor
Samie Wolfe· Administrative Staff
Soraia Silva Romão· Administrative Staffin
Tim Richardson· Strategic Advisorin
Venkat Reddy· Chief Science Officer

What they invest in

from 7 of 42 portfolio companies

Biotech ×5AI & Machine Learning ×3Healthtech ×3Medical Devices ×3Deep Tech ×2Digital Health ×2FemTech ×1New Materials ×1

HQs:United States×7

Investments · 42 tracked

founders shown can be your intro path

By year:2025 · 12024 · 22023 · 14 dated

Brainbox Solutionsbrainboxinc.cominNov 2023SEC filingmedium confidence

BRAINBox Solutions develops a diagnostic and prognostic platform for mild traumatic brain injury that combines blood biomarker panels, neurocognitive testing, and AI-driven scoring to provide objective evidence of injury and predict post-injury symptoms.

AI & Machine LearningBiotechHealthtechMedical DevicesHouston, US

Robert Sledd(Director)Marc Goldberg(Director)Donna Edmonds(Executive Officer, Director)Steve Wallace(Executive Officer)Scott Gazelle(Director)Vikram Chaudhery(Director)

Board seatVikram Chaudhery· per SEC Form D · $18.5M raise · filed Nov 2023

Glyphic Biotechnologies, Inc.Feb 2024SEC filingmedium confidence

New York, US

Board seatCraig Asher· per SEC Form D · $52.9M raise · filed Feb 2024

Simbiosyssimbiosys.comin𝕏Jan 2025SEC filingmedium confidence

Simbiosys develops AI-powered 3D visualization and diagnostic technology that converts 2D medical imaging into interactive 3D digital tumor models to support surgical planning and patient treatment.

AI & Machine LearningBiotechDigital HealthMedical DevicesChicago, US

Joseph Peterson(Executive Officer, Director)Stacey Stevens(Executive Officer, Director)John A Cole(Executive Officer)

BoardLucy Coassin(Director)Ronnie Andrews(Director)

Board seatVikram Chaudhery· per SEC Form D · $8M raise · filed Jan 2025

Switchback Systems, Inc.Aug 2024SEC filingmedium confidence

Saanta Cruz, US

Board seatCraig Asher· per SEC Form D · $15M raise · filed Aug 2024

Abbelightabbelight.com
Accelmedx

Linking CRISPR to single cell genomics with DNA-RAM

Alida Bioalidabio.comin
Axoiyabioaxoiyabio.com
Base Pair Biology
Basilard BioTechbasilardbiotech.comin
Biocellisbiocellis.comin
Breathwalk

Novel clinical sample collection from breath

ClearCut Surgicalin

HealthtechBoston, US

Jeffery John Caputo(Executive Officer, Director)Alex Yang(Cofounder)

Constructive Bioconstructive.bioin𝕏

Constructive develops synthetic biology technology using recoded genomes and engineered tRNAs to incorporate novel chemical building blocks into proteins, enabling new therapeutics, materials, and manufacturing applications.

BiotechDeep TechNew Materials

Cryoveritascryoveritas.com
Detectivebiodetectivebio.com
Dyno Therapeuticsdynotx.comin𝕏

Dyno Therapeutics develops artificial intelligence-powered genetic technologies for gene therapy, specifically engineering adeno-associated virus (AAV) capsids to improve gene delivery for treating genetic diseases.

AI & Machine LearningBiotechWatertown, US

Eric Kelsic(CEO & Cofounder)Sam Sinai(Vice President, Head of ML & Cofounder)Adrian Veres(Chief Scientific Officer & Cofounder)George Church(Scientific Cofounder)Tomas Bjorklund(Scientific Co-founder)Alan Crane(Executive Chairman & Cofounder, Polaris Entrepreneur Partner)

Elenihealthelenihealth.comin
Ennovatetxennovatetx.com
Exodigmexodigm.com
Generalinceptiontxgeneralinceptiontx.com
Hermesbioscienceshermesbiosciences.comin

Hermes Biosciences develops a benchtop extracellular vesicle isolation system that purifies exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.

BiotechDeep TechMedical Devices

Igniter Management

Bridging the gap between conceptualization and realization

Inapillinapill.com
Jounce Therapeutics

Targeting RNA modifying enzymes in autoimmunity

Kindbodykindbody.comin𝕏

Kindbody provides fertility care services including egg freezing, IVF, and family-building support for individuals and couples, with direct clinical care delivered through employee benefits, financing, and insurance options.

Digital HealthFemTechHealthtechSan Francisco, US

Dr. Lynn Westphal(Co-founder)Kathy Harris(Director)Cheryl Pegus(Director)Ellen Hukkelhoven(Director)Annbeth Eschbach(Director)Stuart Ellman(Director)

Nema Therapeutics

Single-molecule protein sequencing for unbiased high depth proteomics

Originpeptidesoriginpeptides.comin
Partillionpartillion.comin
Pharmacelerapharmacelera.comin𝕏
Planetsmartplanetsmart.coin
Roxbiosensroxbiosens.com
Scellgenscellgen.com
Surf Therapeuticssurftherapeutics.comin
Switchbacksysswitchbacksys.comin
Synthbiomesynthbiome.com
Tactiletxtactiletx.com
Taviratxtaviratx.comin
Trenchtxtrenchtx.com
Wespranwespran.comin
XCUR Therapeutics

Developing a vein-to-vein autologous cell therapy manufacturing system

Xeraenergyxeraenergy.com

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Frequently asked questions

What stage does GENERAL INCEPTION invest at?
GENERAL INCEPTION invests at the Pre-Seed, Seed stages.
What sectors does GENERAL INCEPTION focus on?
GENERAL INCEPTION focuses on Biotech, Deep Tech, Medical Devices, Sector Agnostic.
Where is GENERAL INCEPTION located?
GENERAL INCEPTION is headquartered in Palo Alto, US.
Does GENERAL INCEPTION lead rounds?
GENERAL INCEPTION typically participates in rounds rather than leading them.

Images

GENERAL INCEPTION photo

Co-investors · 2

ARCH Venture Partners

ARCH Venture Partners is a venture capital firm that backs and helps build transformational companies, with a strong focus on the life sciences and biotech sector.

$50K – $250M
Northpond Ventures

Northpond Ventures is a science- and technology-driven investment firm that backs breakthrough businesses aiming to have a significant impact on humanity.

$100K – $5M

Firms observed investing alongside GENERAL INCEPTION, from public investor directories. Shared companies are the overlap with GENERAL INCEPTION's recorded portfolio.

Similar investors

Featured in lists